SZLS.TO - StageZero Life Sciences Ltd.

Toronto - Toronto Delayed Price. Currency in CAD
0.0650
+0.0050 (+8.33%)
As of 2:16PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close0.0600
Open0.0650
Bid0.0600 x N/A
Ask0.0650 x N/A
Day's Range0.0600 - 0.0650
52 Week Range0.0300 - 0.1800
Volume1,368,933
Avg. Volume4,522,748
Market Cap24.652M
Beta (5Y Monthly)5.74
PE Ratio (TTM)N/A
EPS (TTM)-0.0040
Earnings DateApr. 05, 2019 - Apr. 08, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est0.50
  • The Canadian Press

    Most actively traded companies on the TSX

    TORONTO — Some of the most active companies traded Wednesday on the Toronto Stock Exchange:Toronto Stock Exchange (15,629.19, up 33.69 points.)The Toronto-Dominion Bank (TSX:TD). Financials. Up eight cents, or 0.13 per cent, to $60.30 on 21.8 million shares.StageZero Life Sciences Ltd. (TSX:SZLS). Health care. Up half a cent, or 9.09 per cent, to six cents on 9 million shares.St. Augustine Gold and Copper (TSX:SAU). Materials. Down 5.5 cents, or 39.29 per cent, to 8.5 cents on 8.3 million shares.Kinross Gold Corp. (TSX:K). Materials. Up 15 cents, or 1.48 per cent, to $10.26 on 6.1 million shares.B2Gold Corp. (TSX:BTO). Materials. Up 19 cents, or 2.4 per cent, to $8.12 on 5.7 million shares.The Bank of Nova Scotia. (TSX:BNS). Financials. Down 22 cents, or 0.4 per cent, to $54.73 on 5.3 million shares.Companies in the news:Transat AT (TSX:TRZ). Down five cents to $5.51. Air Transat is looking to reduce greenhouse gas emissions from its airplanes by using jet fuel made from kerosene in a process that captures carbon dioxide produced by large industrial emitters. The Montreal-based airline has signed an agreement with SAF+ Consortium, which is finalizing the fabrication of a pilot plant in Montreal to make the kerosene. The kerosene is then converted to synthetic jet fuel which is estimated to have an 80 per cent lower carbon footprint than conventional jet fuel. Air Transat says it will buy a significant portion of the future sustainable aviation fuel (SAF) production. SAF + Consortium chief technical officer, Alexandru Iordan, says demand for sustainable aviation fuel will almost double annually for the next 30 years.DavidsTea — DavidsTea is seeking court protection from creditors so it can continue operating while it restructures and plans to close a significant number of its stores. The Montreal-based company said Wednesday it will seek an order in Quebec Superior Court to allow it to restructure under the Companies' Creditors Arrangement Act. It also plans to seek similar orders for its U.S. subsidiary under Chapter 15 of the U.S. Bankruptcy Code. The company said during the restructuring process it plans to continue operating online through davidstea.com and its wholesale distribution channel, which supplies grocery stores and pharmacies. The chain's stores have been shut since March 17 due to the COVID-19 pandemic. It had warned in mid-June that it hadn't paid rent on any of its stores for April, May and June and that it may seek a formal restructuring.This report by The Canadian Press was first published July 8, 2020.The Canadian Press

  • ACCESSWIRE

    StageZero Life Sciences Announces Corporate Update

    TORONTO, ON / ACCESSWIRE / July 2, 2020 / StageZero Life Sciences (TSX:SZLS) (''StageZero Life Sciences'' or the ''Company'') today announced a corporate update on its business. The Company was pleased ...

  • ACCESSWIRE

    StageZero Life Sciences Ltd. Announces Closing of Public Offering for Proceeds of $4.6 million

    TORONTO, ON / ACCESSWIRE / June 29, 2020 / StageZero Life Sciences Ltd. (SZLS.TO) (the "Company") is pleased to announce that is has closed its previously announced public offering of 66,176,100 units of the Company (the "Units") at a price of $0.07 per Unit (the "Offering Price") for aggregate gross proceeds of $4,632,327 (the "Offering"). The Offering was made pursuant to an agency agreement effective June 22, 2020 with Echelon Wealth Partners Inc. and Clarus Securities Inc. (collectively, the "Agents"). Each Unit was comprised of one common share of the Company (each, a "Common Share") and one common share purchase warrant (each, a "Warrant").

  • CNW Group

    IIROC Trading Halt - SZLS.WT

    TORONTO , June 29, 2020 /CNW/ - The following issues have been halted by IIROC: Company: StageZero Life Sciences Ltd. Warrants TSX Symbol: SZLS.WT Reason: Pending Closing Halt Time (ET): 8:00 AM IIROC ...

  • ACCESSWIRE

    StageZero Life Sciences Announces Issuance of Receipt for Final Prospectus and Conditional Listing Approval

    The Toronto Stock Exchange has conditionally approved the listing of the common shares (the "Shares") partially comprising the units (the "Units") offered by the prospectus, the Shares issuable upon exercise of the warrants (the "Warrants") partially comprising the Units, the shares issuable upon exercise of broker warrants and compensation warrants granted to the agents for the prospectus offering. Listing is subject to the Company fulfilling all of the requirements of the Toronto Stock Exchange on or before August 31, 2020. The Toronto Stock Exchange has conditionally approved the listing of the Warrants.

  • ACCESSWIRE

    StageZero Life Sciences Ltd. Files Amended and Restated First Quarter Financial Statements and Management Discussion and Analysis

    TORONTO, CANADA / ACCESSWIRE / June 18, 2020 / StageZero Life Sciences Ltd. (TSX:SZLS) (" StageZero ", or the " Company ") has filed its amended and restated management discussion and ...

  • CNW Group

    C-Suite At The Open: James Howard-Tripp, Chief Executive Officer, StageZero Life Sciences Ltd., tells his Company's Story. Filmed in May, 2020

    TORONTO , June 11, 2020 /CNW/ -    https://www.youtube.com/watch?v=QifanjnKxWo The C-Suite At the Open video interview series highlights the unique perspectives of listed companies on Toronto Stock Exchange ...

  • CNW Group

    IIROC Trade Resumption - SZLS

    TORONTO , June 2, 2020 /CNW/ - Trading resumes in: Company: StageZero Life Sciences Ltd. TSX Symbol: SZLS (All Issues) Resumption (ET): 3‎:15‎:‎00‎ ‎PM IIROC can make a decision to impose a temporary suspension ...

  • StageZero Life Sciences Ltd. Announces Pricing of Public Offering
    CNW Group

    StageZero Life Sciences Ltd. Announces Pricing of Public Offering

    Each Unit will be offered at a price of $0.07 per Unit (the "Offering Price") and will be comprised of one common share of the Company (a "Common Share") and one common share purchase warrant (a "Warrant"). Each Warrant will entitle the holder thereof to purchase one Common Share at an exercise price of $0.09 for a period of 36 months following the closing date of the Offering.

  • CNW Group

    IIROC Trading Halt - SZLS

    IIROC Trading Halt - SZLS

  • StageZero Life Sciences Ltd. Announces Overnight Marketed Public Offering
    CNW Group

    StageZero Life Sciences Ltd. Announces Overnight Marketed Public Offering

    Each Unit will consist of one common share in the capital of the Company (each, a "Common Share") and one-half of one common share purchase warrant (each full warrant, a "Warrant"). The Offering will be conducted by Echelon Wealth Partners Inc. ("Echelon") and Clarus Securities Inc. ("Clarus", and collectively with Echelon, the "Agents") as co-lead Agents and joint bookrunners.

  • ACCESSWIRE

    StageZero Life Sciences Announces Q1 2020 Progress Update

    TORONTO, ON / ACCESSWIRE / June 1 , 2020 / StageZero Life Sciences, Ltd (TSX:SZLS) ("StageZero" or the "Company") today announced operational results for the three month period ended ...

  • ACCESSWIRE

    StageZero Life Sciences Discusses Testing for COVID-19 Beginning to Go Live and Whole Blood Diagnostic Test, Aristotle(R), in New Video Interview on SNN Network

    LOS ANGELES, CA / ACCESSWIRE / May 28, 2020 / SNN Network, The Official Small-, Micro- and Nano-Cap News Source™, today published a new Video Interview with James Howard-Tripp, Chairman and CEO of StageZero ...

  • ACCESSWIRE

    StageZero Life Sciences Announces a Delay in its Q1 Filings

    TORONTO, ON / ACCESSWIRE / May 20, 2020 / StageZero Life Sciences, Ltd (TSX:SZLS) ("StageZero" or the "Company") today announced that due to the disruption caused by COVID-19 and its ...

  • ACCESSWIRE

    StageZero Life Sciences Announces Q4 and Full Year 2019 Results and Provides Progress Update

    TORONTO, ON / ACCESSWIRE / May 20, 2020 / StageZero Life Sciences (SZLS.TO) (''StageZero'' or the ''Company'') today announced operational and financial results for the three-month and twelve-month periods ended December 31, 2019 and provided a progress update on its business. Full Year 2019 saw consolidation of the business under the StageZero Life Sciences banner and the building out of key commercialization infrastructure that will prove critical in 2020.

  • ACCESSWIRE

    StageZero Life Sciences Partners with UDoTest to Link Physicians and Their Patients to Urgent COVID-19 Testing

    StageZero Life Sciences will offer, via UDoTest's online platform, PCR testing for the live virus, as well as antibody tests to test for past infection. "This is a highly coordinated effort to deliver COVID-19 testing more efficiently around the country," says James Howard-Tripp, Chairman and CEO of StageZero Life Sciences.

  • ACCESSWIRE

    CORRECTION: StageZero Announces Fourth Quarter 2019 Results and Year End Investor Call

    In the news release, "StageZero Announces Fourth Quarter 2019 Results and Year End Investor Call", issued May 13, 2020 by StageZero Life Sciences Limited over Accesswire, we are advised by the ...

  • ACCESSWIRE

    StageZero Announces Fourth Quarter 2019 Results and Year End Investor Call

    TORONTO, ON / ACCESSWIRE / May 13, 2020 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS) today announced that it will release its Fourth Quarter 2019 operational ...

  • ACCESSWIRE

    StageZero Life Sciences Announces Completion of the Convertible Security Funding Agreement with LIND

    TORONTO, ON / ACCESSWIRE / May 12, 2020 / StageZero Life Sciences, Ltd (TSX:SZLS) ("StageZero" or the "Company") today announced that the Convertible Security Funding Agreement for ...

  • ACCESSWIRE

    StageZero Life Sciences Announces Enhanced Relationship with Phleb-Finders

    TORONTO, ON / ACCESSWIRE / May 4, 2020 / StageZero Life Sciences, Ltd (TSX:SZLS) ("StageZero" or the "Company") today announced an enhanced relationship with Phleb-Finders. Phleb-Finders ...

  • ACCESSWIRE

    StageZero Life Sciences Provides an Update on Testing for COVID-19 In the USA

    The Company offers the PCR-based nucleic acid tests as well qualitative antibody testing. Quantitative antibody testing will be added once fully validated and approved. The Company will approach antibody testing as a two-step process.

  • ACCESSWIRE

    StageZero Life Sciences Initiates Testing for COVID-19 In the USA

    The Company will offer both the PCR-based nucleic acid tests as well qualitative antibody testing. Quantitative antibody testing will be added once fully validated and approved. The Company is first directing its testing to healthcare groups and frontline workers, which will include employers of frontline workers.

  • ACCESSWIRE

    Amended Press Release: StageZero Life Sciences Financials Update

    The Company now, however, due to disruption of the audit process caused by the Covid-19 crisis, intends to rely on exemptions recently granted by Canadian securities regulatory authorities that allow it to delay the issue of the 2019 Financial Statements, the 2019 MD&A and the 2019 AIF. Without the exemptions, the Company would be required to issue and file its 2019 Annual Financial Statements, 2019 MD&A and 2019 AIF by 30 March 2020. The Company intends to rely on the exemptions to provide its Board of Directors and its recently appointed auditors adequate time to complete the full year audit.

  • ACCESSWIRE

    StageZero Life Sciences Announces Publication of Abstract at American Society of Clinical Oncology

    This is the first step to presenting the Aristotle cancer data to the scientific community at large. In a series of studies, we and others have demonstrated that RNA profiles generated from circulating blood can be used to identify patients with a number of conditions, including: lung cancer, bladder cancer, colorectal cancer, osteoarthritis, schizophrenia and bipolar disorder.

  • ACCESSWIRE

    StageZero Life Sciences preparing to offer COVID-19 testing in the U.S. and Canada

    StageZero will offer both the serology point-of-care and lab-based PCR tests. StageZero operates a CLIA certified, high complexity laboratory in Richmond, Virginia which is qualified to perform the testing for COVID-19.